Connection
Greggory LaBerge to Genotype
This is a "connection" page, showing publications Greggory LaBerge has written about Genotype.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.142 |
|
|
|
-
LaBerge GS, Bennett DC, Fain PR, Spritz RA. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol. 2008 Jul; 128(7):1757-62.
Score: 0.052
-
Danielson PB, Shelton RJ, LaBerge GS. Clinical applications of denaturing high-performance liquid chromatography-based genotyping. Croat Med J. 2003 Aug; 44(4):447-54.
Score: 0.038
-
Kooakachai M, LaBerge G, Santorico SA. A new framework to test parent-child and full sibling relationships with population substructure. Forensic Sci Int. 2019 Dec; 305:110012.
Score: 0.029
-
Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007 Mar 22; 356(12):1216-25.
Score: 0.012
-
Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003 Jun; 72(6):1560-4.
Score: 0.009